DBD vs SYK · P/E 28, rev $1.82B vs P/E 35, rev $6.59B
Diebold Nixdorf, Incorporated (DBD) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported DBD revenue for 2026-06-30 was $1.82B. Net income was $20.5M. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
DBD currently screens at market cap $2.82B and trailing P/E 28.1. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the DBD and SYK stock pages for the full models.
Not investment advice.